Showing 20 of 203 recruiting trials for “combined-hepatocellular-carcinoma-and-cholangiocarcinoma”
Y-90 Treatment Response Using Transarterial Radioembolization
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
👨⚕️ Dou-sheng Bai, Clinical Medical College, Yangzhou University📍 1 site📅 Started Sep 2025View details ↗
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC
Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
RecruitingNCT07100405 ↗
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma
RecruitingNCT07345247 ↗
RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
👨⚕️ Jinbo Yue, Doctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Jul 2025View details ↗
Study of GV20-0251 in Participants With Solid Tumor Malignancies
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
👨⚕️ Weidong Han, Ph.D, Biotherapeutic Department, Chinese PLA General Hospital📍 1 site📅 Started Jun 2025View details ↗
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
👨⚕️ Tingbo Liang, MD, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT06877637 ↗
On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
RecruitingNCT06999174 ↗
Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →